ResearcherAffiliated Hospital of Jiangsu UniversityNo recent work listed

Min Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8245-4695; OpenAlex author ID A5090193731. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper

Papers 1

ABCB2 (TAP1) as the downstream target of SHH signaling enhances pancreatic ductal adenocarcinoma drug resistance. Co-author DOI 10.1016/j.canlet.2013.01.002 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Youli Zhang · 1 shared paper, 2013 · strength 0.04
- Paper ABCB2 (TAP1) as the downstream target of SHH signaling enhances pancreatic ductal adenocarcinoma drug resistance. DOI 10.1016/j.canlet.2013.01.002 ↗
Xiangyu Kong · 1 shared paper, 2013 · strength 0.04
- Paper ABCB2 (TAP1) as the downstream target of SHH signaling enhances pancreatic ductal adenocarcinoma drug resistance. DOI 10.1016/j.canlet.2013.01.002 ↗
Lei Li · 1 shared paper, 2013 · strength 0.04
- Paper ABCB2 (TAP1) as the downstream target of SHH signaling enhances pancreatic ductal adenocarcinoma drug resistance. DOI 10.1016/j.canlet.2013.01.002 ↗
Haojie Huang · 1 shared paper, 2013 · strength 0.04
- Paper ABCB2 (TAP1) as the downstream target of SHH signaling enhances pancreatic ductal adenocarcinoma drug resistance. DOI 10.1016/j.canlet.2013.01.002 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.